Mercier Johanna sold $3.9M of GILD
Mercier Johanna (Chief Comm & Corp Aff Officer) sold 28,000 shares of GILEAD SCIENCES, INC. (GILD) at an average of $137.64 ($137.36–$138.04, $3.85M total) across 2 trades on 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed fact is the insider’s sale details (shares, price range, total value) and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may treat this as low-signal insider activity because it is explicitly under a 10b5-1 plan, with limited incremental information for valuation.
What to watch
The article provides sale size and price range but not context like total compensation, prior sale cadence, or whether other insiders also sold around the same window.
Background
The article is a SEC Form 4 insider transaction disclosure for Gilead Sciences, filed on 2026-08-18.
Ticker impact
Gilead insider Mercier Johanna sold about 28,000 shares in open-market trades at roughly $137.37 to $138.04 on 2026-08-17.
Low likelihood of a sustained price move solely from this filing; any reaction is likely muted.
The filing specifies an open-market sale and a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with internal caution, so traders may still watch for follow-on disclosures.
Key entities
- issuerGilead Sciences, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderMercier Johanna
Chief Comm and Corp Aff Officer who sold shares.
- trading mechanismRule 10b5-1 plan
Pre-arranged plan cited as Yes in the filing.
